These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

805 related items for PubMed ID: 33735876

  • 1. Biological Therapies for Atopic Dermatitis: A Systematic Review.
    Zhou S, Qi F, Gong Y, Zhang J, Zhu B.
    Dermatology; 2021; 237(4):542-552. PubMed ID: 33735876
    [Abstract] [Full Text] [Related]

  • 2. Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis.
    Edwards SJ, Karner C, Jhita T, Barton S, Marceniuk G, Yiu ZZN, Wittmann M.
    Health Technol Assess; 2024 Jan; 28(4):1-113. PubMed ID: 38343072
    [Abstract] [Full Text] [Related]

  • 3. [Current and upcoming treatments of adult atopic dermatitis].
    Lacour JP.
    Ann Dermatol Venereol; 2017 Dec; 144 Suppl 5():VS29-VS37. PubMed ID: 29433635
    [Abstract] [Full Text] [Related]

  • 4. Are Biologics Efficacious in Atopic Dermatitis? A Systematic Review and Meta-Analysis.
    Snast I, Reiter O, Hodak E, Friedland R, Mimouni D, Leshem YA.
    Am J Clin Dermatol; 2018 Apr; 19(2):145-165. PubMed ID: 29098604
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Janus kinase inhibitors for atopic dermatitis: a promising treatment modality.
    Cartron AM, Nguyen TH, Roh YS, Kwatra MM, Kwatra SG.
    Clin Exp Dermatol; 2021 Jul; 46(5):820-824. PubMed ID: 33484582
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Novel topical and systemic therapies in atopic dermatitis.
    Suga H, Sato S.
    Immunol Med; 2019 Jun; 42(2):84-93. PubMed ID: 31318324
    [Abstract] [Full Text] [Related]

  • 11. JAK inhibitors in dermatology: The promise of a new drug class.
    Damsky W, King BA.
    J Am Acad Dermatol; 2017 Apr; 76(4):736-744. PubMed ID: 28139263
    [Abstract] [Full Text] [Related]

  • 12. [Not Available].
    Lacour JP.
    Ann Dermatol Venereol; 2019 Dec; 146(12S3):12S76-12S84. PubMed ID: 31997736
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Oral small molecules for the treatment of atopic dermatitis: a systematic review.
    Mobasher P, Heydari Seradj M, Raffi J, Juhasz M, Atanaskova Mesinkovska N.
    J Dermatolog Treat; 2019 Sep; 30(6):550-557. PubMed ID: 30501539
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparative efficacy and safety of abrocitinib, baricitinib, and upadacitinib for moderate-to-severe atopic dermatitis: A network meta-analysis.
    Wan H, Jia H, Xia T, Zhang D.
    Dermatol Ther; 2022 Sep; 35(9):e15636. PubMed ID: 35703351
    [Abstract] [Full Text] [Related]

  • 20. Acute spondyloarthritis developing during successful treatment with dupilumab for severe atopic dermatitis.
    Raimondo A, Guglielmi G, Marino C, Ligrone L, Lembo S.
    Clin Exp Dermatol; 2022 Mar; 47(3):592-593. PubMed ID: 34655234
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.